Affibody® molecules are small therapeutic proteins which mimics antibody functionality. This is a report of several methods for increasing productivity and yield in recombinant production of Affibody® molecules. This literature study shows several steps in the production line which can be optimised, several novel methods for cultivating and harvesting cells and purication of proteins. There is also a section about validation of therapeutic protein production according to The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) are presented.
| Identifer | oai:union.ndltd.org:UPSALLA1/oai:DiVA.org:uu-352528 |
| Date | January 2018 |
| Creators | Engström, Mathias, Pontén, Olle, Philip, Carlsson, Bahnam, Nadeen, Strömberg, Ella, Westlin, Oskar |
| Publisher | Uppsala universitet, Institutionen för biologisk grundutbildning, Uppsala universitet, Institutionen för biologisk grundutbildning, Uppsala universitet, Institutionen för biologisk grundutbildning, Uppsala universitet, Institutionen för biologisk grundutbildning, Uppsala universitet, Institutionen för biologisk grundutbildning, Uppsala universitet, Institutionen för biologisk grundutbildning |
| Source Sets | DiVA Archive at Upsalla University |
| Language | English |
| Detected Language | English |
| Type | Student thesis, info:eu-repo/semantics/bachelorThesis, text |
| Format | application/pdf |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.002 seconds